Table of Content 1 Introduction 1.1 Objective of the Study 1.2 Definition of the Market 1.3 Market Scope 1.3.1 Market Segment by Type, Application and Marketing Channel 1.3.2 Major Regions Covered (North America, Europe, Asia Pacific, Mid East & Africa) 1.4 Years Considered for the Study (2014-2026) 1.5 Currency Considered (U.S. Dollar) 1.6 Stakeholders 2 Key Findings of the Study 3 Market Dynamics 3.1 Driving Factors for this Market 3.2 Factors Challenging the Market 3.3 Opportunities of the Global RNAi For Therapeutic Market (Regions, Growing/Emerging Downstream Market Analysis) 3.4 Technological and Market Developments in the RNAi For Therapeutic Market 3.5 Industry News by Region 3.6 Regulatory Scenario by Region/Country 3.7 Market Investment Scenario Strategic Recommendations Analysis 4 Value Chain of the RNAi For Therapeutic Market 4.1 Value Chain Status 4.2 Upstream Raw Material Analysis 4.3 Midstream Major Company Analysis (by Manufacturing Base, by Product Type) 4.4 Distributors/Traders 4.5 Downstream Major Customer Analysis (by Region) 5 Global RNAi For Therapeutic Market-Segmentation by Type 5.1 siRNA 5.2 miRNA 5.3 shRNA 6 Global RNAi For Therapeutic Market-Segmentation by Application 6.1 Cancer 6.2 Cardiovascular 6.3 HBV 7 Global RNAi For Therapeutic Market-Segmentation by Marketing Channel 7.1 Traditional Marketing Channel (Offline) 7.2 Online Channel 8 Competitive Intelligence – Company Profiles 8.1 Arrowhead 8.1.1 Arrowhead Profile 8.1.2 Arrowhead Sales, Growth Rate and Global Market Share from 2014-2019E 8.1.3 Arrowhead Product/Solution Launches and Enhancements Analysis 8.1.4 Arrowhead Business Overview/Recent Development/Acquisitions 8.2 MiRagen Therapeutics 8.2.1 MiRagen Therapeutics Profile 8.2.2 MiRagen Therapeutics Sales, Growth Rate and Global Market Share from 2014-2019E 8.2.3 MiRagen Therapeutics Product/Solution Launches and Enhancements Analysis 8.2.4 MiRagen Therapeutics Business Overview/Recent Development/Acquisitions 8.3 Gradalis 8.3.1 Gradalis Profile 8.3.2 Gradalis Sales, Growth Rate and Global Market Share from 2014-2019E 8.3.3 Gradalis Product/Solution Launches and Enhancements Analysis 8.3.4 Gradalis Business Overview/Recent Development/Acquisitions 8.4 Mirna Therapeutics 8.4.1 Mirna Therapeutics Profile 8.4.2 Mirna Therapeutics Sales, Growth Rate and Global Market Share from 2014-2019E 8.4.3 Mirna Therapeutics Product/Solution Launches and Enhancements Analysis 8.4.4 Mirna Therapeutics Business Overview/Recent Development/Acquisitions 8.5 RXi Pharmaceuticals 8.5.1 RXi Pharmaceuticals Profile 8.5.2 RXi Pharmaceuticals Sales, Growth Rate and Global Market Share from 2014-2019E 8.5.3 RXi Pharmaceuticals Product/Solution Launches and Enhancements Analysis 8.5.4 RXi Pharmaceuticals Business Overview/Recent Development/Acquisitions 8.6 Alnylam Pharmaceuticals 8.6.1 Alnylam Pharmaceuticals Profile 8.6.2 Alnylam Pharmaceuticals Sales, Growth Rate and Global Market Share from 2014-2019E 8.6.3 Alnylam Pharmaceuticals Product/Solution Launches and Enhancements Analysis 8.6.4 Alnylam Pharmaceuticals Business Overview/Recent Development/Acquisitions 8.7 Quark Pharmaceuticals 8.7.1 Quark Pharmaceuticals Profile 8.7.2 Quark Pharmaceuticals Sales, Growth Rate and Global Market Share from 2014-2019E 8.7.3 Quark Pharmaceuticals Product/Solution Launches and Enhancements Analysis 8.7.4 Quark Pharmaceuticals Business Overview/Recent Development/Acquisitions 8.8 Sirnaomics 8.8.1 Sirnaomics Profile 8.8.2 Sirnaomics Sales, Growth Rate and Global Market Share from 2014-2019E 8.8.3 Sirnaomics Product/Solution Launches and Enhancements Analysis 8.8.4 Sirnaomics Business Overview/Recent Development/Acquisitions 8.9 Dicerna Pharmaceuticals 8.9.1 Dicerna Pharmaceuticals Profile 8.9.2 Dicerna Pharmaceuticals Sales, Growth Rate and Global Market Share from 2014-2019E 8.9.3 Dicerna Pharmaceuticals Product/Solution Launches and Enhancements Analysis 8.9.4 Dicerna Pharmaceuticals Business Overview/Recent Development/Acquisitions 9 Global RNAi For Therapeutic Market-Segmentation by Geography 10 North America 10.1 North America RNAi For Therapeutic Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2014-2019E 10.2 North America RNAi For Therapeutic Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2014-2019E 10.3 North America RNAi For Therapeutic Production Analysis from 2014-2019E 10.4 North America RNAi For Therapeutic Consumption Analysis from 2014-2019E 10.5 North America RNAi For Therapeutic Import and Export from 2014-2019E 10.6 North America RNAi For Therapeutic Value, Production and Market Share by Type (2014-2019E) 10.7 North America RNAi For Therapeutic Consumption, Value and Market Share by Application (2014-2019E) 10.8 North America RNAi For Therapeutic by Country (United States, Canada) 10.8.1 North America RNAi For Therapeutic Sales by Country (2014-2019E) 10.8.2 North America RNAi For Therapeutic Consumption Value by Country (2014-2019E) 10.9 North America RNAi For Therapeutic Market PEST Analysis 11 Europe 11.1 Europe RNAi For Therapeutic Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2014-2019E 11.2 Europe RNAi For Therapeutic Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2014-2019E 11.3 Europe RNAi For Therapeutic Production Analysis from 2014-2019E 11.4 Europe RNAi For Therapeutic Consumption Analysis from 2014-2019E 11.5 Europe RNAi For Therapeutic Import and Export from 2014-2019E 11.6 Europe RNAi For Therapeutic Value, Production and Market Share by Type (2014-2019E) 11.7 Europe RNAi For Therapeutic Consumption, Value and Market Share by Application (2014-2019E) 11.8 Europe RNAi For Therapeutic by Country (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden, Poland, Belgium) 11.8.1 Europe RNAi For Therapeutic Sales by Country (2014-2019E) 11.8.2 Europe RNAi For Therapeutic Consumption Value by Country (2014-2019E) 11.9 Europe RNAi For Therapeutic Market PEST Analysis 12 Asia-Pacific 12.1 Asia-Pacific RNAi For Therapeutic Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2014-2019E 12.2 Asia-Pacific RNAi For Therapeutic Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2014-2019E 12.3 Asia-Pacific RNAi For Therapeutic Production Analysis from 2014-2019E 12.4 Asia-Pacific RNAi For Therapeutic Consumption Analysis from 2014-2019E 12.5 Asia-Pacific RNAi For Therapeutic Import and Export from 2014-2019E 12.6 Asia-Pacific RNAi For Therapeutic Value, Production and Market Share by Type (2014-2019E) 12.7 Asia-Pacific RNAi For Therapeutic Consumption, Value and Market Share by Application (2014-2019E) 12.8 Asia-Pacific RNAi For Therapeutic by Country (China, Japan, South Korea, Australia, India, Taiwan, Indonesia, Thailand, Philippines, Malaysia) 12.8.1 Asia-Pacific RNAi For Therapeutic Sales by Country (2014-2019E) 12.8.2 Asia-Pacific RNAi For Therapeutic Consumption Value by Country (2014-2019E) 12.9 Asia-Pacific RNAi For Therapeutic Market PEST Analysis 13 Latin America 13.1 Latin America RNAi For Therapeutic Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2014-2019E 13.2 Latin America RNAi For Therapeutic Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2014-2019E 13.3 Latin America RNAi For Therapeutic Production Analysis from 2014-2019E 13.4 Latin America RNAi For Therapeutic Consumption Analysis from 2014-2019E 13.5 Latin America RNAi For Therapeutic Import and Export from 2014-2019E 13.6 Latin America RNAi For Therapeutic Value, Production and Market Share by Type (2014-2019E) 13.7 Latin America RNAi For Therapeutic Consumption, Value and Market Share by Application (2014-2019E) 13.8 Latin America RNAi For Therapeutic by Country (Brazil, Mexico, Argentina, Columbia, Chile) 13.8.1 Latin America RNAi For Therapeutic Sales by Country (2014-2019E) 13.8.2 Latin America RNAi For Therapeutic Consumption Value by Country (2014-2019E) 13.9 Latin America RNAi For Therapeutic Market PEST Analysis 14 Middle East & Africa 14.1 Middle East & Africa RNAi For Therapeutic Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2014-2019E 14.2 Middle East & Africa RNAi For Therapeutic Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2014-2019E 14.3 Middle East & Africa RNAi For Therapeutic Production Analysis from 2014-2019E 14.4 Middle East & Africa RNAi For Therapeutic Consumption Analysis from 2014-2019E 14.5 Middle East & Africa RNAi For Therapeutic Import and Export from 2014-2019E 14.6 Middle East & Africa RNAi For Therapeutic Value, Production and Market Share by Type (2014-2019E) 14.7 Middle East & Africa RNAi For Therapeutic Consumption, Value and Market Share by Application (2014-2019E) 14.8 Middle East & Africa RNAi For Therapeutic by Country (Saudi Arabia, UAE, Egypt, Nigeria, South Africa) 14.8.1 Middle East & Africa RNAi For Therapeutic Sales by Country (2014-2019E) 14.8.2 Middle East & Africa RNAi For Therapeutic Consumption Value by Country (2014-2019E) 14.9 Middle East & Africa RNAi For Therapeutic Market PEST Analysis 15 Future Forecast of the Global RNAi For Therapeutic Market from 2018-2026 15.1 Future Forecast of the Global RNAi For Therapeutic Market from 2019-2026 Segment by Region 15.2 Global RNAi For Therapeutic Production and Growth Rate Forecast by Type (2019-2026) 15.3 Global RNAi For Therapeutic Consumption and Growth Rate Forecast by Application (2019-2026) 16 Appendix 16.1 Methodology 16.2 Research Data Source

List of Tables and Figures Global RNAi For Therapeutic Market Value ($) and Growth Rate of RNAi For Therapeutic from 2014-2026 Global RNAi For Therapeutic Production and Growth Rate Segment by Product Type from 2014-2026F Global RNAi For Therapeutic Consumption and Growth Rate Segment by Application from 2014-2019E Figure RNAi For Therapeutic Picture Table Product Specifications of RNAi For Therapeutic Table Driving Factors for this Market Table Industry News of RNAi For Therapeutic Market Figure Value Chain Status of RNAi For Therapeutic Table Midstream Major Company Analysis (by Manufacturing Base, by Product Type) Table Distributors/Traders Table Downstream Major Customer Analysis (by Region, by Preference) Table Global RNAi For Therapeutic Production and Growth Rate Segment by Product Type from 2014-2019E Table Global RNAi For Therapeutic Value ($) and Growth Rate Segment by Product Type from 2014-2019E Figure siRNA of RNAi For Therapeutic Figure miRNA of RNAi For Therapeutic Figure shRNA of RNAi For Therapeutic Table Global RNAi For Therapeutic Consumption and Growth Rate Segment by Application from 2014-2019E Table Global RNAi For Therapeutic Value ($) and Growth Rate Segment by Application from 2014-2019E Figure Cancer of RNAi For Therapeutic Figure Cardiovascular of RNAi For Therapeutic Figure HBV of RNAi For Therapeutic Table Global RNAi For Therapeutic Consumption and Growth Rate Segment by Marketing Channel from 2014-2019E Table Global RNAi For Therapeutic Value ($) and Growth Rate Segment by Marketing Channel from 2014-2019E Figure Traditional Marketing Channel (Offline) of RNAi For Therapeutic Figure Online Channel of RNAi For Therapeutic Table Arrowhead Profile (Company Name, Plants Distribution, Sales Region) Figure Arrowhead Sales and Growth Rate from 2014-2019E Figure Arrowhead Revenue ($) and Global Market Share from 2014-2019E Table Arrowhead RNAi For Therapeutic Sales, Price, Revenue, Gross Margin (2014-2019E) Table MiRagen Therapeutics Profile (Company Name, Plants Distribution, Sales Region) Figure MiRagen Therapeutics Sales and Growth Rate from 2014-2019E Figure MiRagen Therapeutics Revenue ($) and Global Market Share from 2014-2019E Table MiRagen Therapeutics RNAi For Therapeutic Sales, Price, Revenue, Gross Margin (2014-2019E) Table Gradalis Profile (Company Name, Plants Distribution, Sales Region) Figure Gradalis Sales and Growth Rate from 2014-2019E Figure Gradalis Revenue ($) and Global Market Share from 2014-2019E Table Gradalis RNAi For Therapeutic Sales, Price, Revenue, Gross Margin (2014-2019E) Table Mirna Therapeutics Profile (Company Name, Plants Distribution, Sales Region) Figure Mirna Therapeutics Sales and Growth Rate from 2014-2019E Figure Mirna Therapeutics Revenue ($) and Global Market Share from 2014-2019E Table Mirna Therapeutics RNAi For Therapeutic Sales, Price, Revenue, Gross Margin (2014-2019E) Table RXi Pharmaceuticals Profile (Company Name, Plants Distribution, Sales Region) Figure RXi Pharmaceuticals Sales and Growth Rate from 2014-2019E Figure RXi Pharmaceuticals Revenue ($) and Global Market Share from 2014-2019E Table RXi Pharmaceuticals RNAi For Therapeutic Sales, Price, Revenue, Gross Margin (2014-2019E) Table Alnylam Pharmaceuticals Profile (Company Name, Plants Distribution, Sales Region) Figure Alnylam Pharmaceuticals Sales and Growth Rate from 2014-2019E Figure Alnylam Pharmaceuticals Revenue ($) and Global Market Share from 2014-2019E Table Alnylam Pharmaceuticals RNAi For Therapeutic Sales, Price, Revenue, Gross Margin (2014-2019E) Table Quark Pharmaceuticals Profile (Company Name, Plants Distribution, Sales Region) Figure Quark Pharmaceuticals Sales and Growth Rate from 2014-2019E Figure Quark Pharmaceuticals Revenue ($) and Global Market Share from 2014-2019E Table Quark Pharmaceuticals RNAi For Therapeutic Sales, Price, Revenue, Gross Margin (2014-2019E) Table Sirnaomics Profile (Company Name, Plants Distribution, Sales Region) Figure Sirnaomics Sales and Growth Rate from 2014-2019E Figure Sirnaomics Revenue ($) and Global Market Share from 2014-2019E Table Sirnaomics RNAi For Therapeutic Sales, Price, Revenue, Gross Margin (2014-2019E) Table Dicerna Pharmaceuticals Profile (Company Name, Plants Distribution, Sales Region) Figure Dicerna Pharmaceuticals Sales and Growth Rate from 2014-2019E Figure Dicerna Pharmaceuticals Revenue ($) and Global Market Share from 2014-2019E Table Dicerna Pharmaceuticals RNAi For Therapeutic Sales, Price, Revenue, Gross Margin (2014-2019E) Table Global RNAi For Therapeutic Production Value ($) by Region from 2014-2019E Table Global RNAi For Therapeutic Production Value Share by Region from 2014-2019E Table Global RNAi For Therapeutic Production by Region from 2014-2019E Table Global RNAi For Therapeutic Consumption Value ($) by Region from 2014-2019E Table Global RNAi For Therapeutic Consumption by Region from 2014-2019E Table North America RNAi For Therapeutic Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2014-2019E Table North America RNAi For Therapeutic Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2014-2019E Table North America RNAi For Therapeutic Import and Export from 2014-2019E Table North America RNAi For Therapeutic Value ($) by Type (2014-2019E) Table North America RNAi For Therapeutic Production by Type (2014-2019E) Table North America RNAi For Therapeutic Consumption by Application (2014-2019E) Table North America RNAi For Therapeutic Consumption by Country (2014-2019E) Table North America RNAi For Therapeutic Consumption Value ($) by Country (2014-2019E) Figure North America RNAi For Therapeutic Market PEST Analysis Table Europe RNAi For Therapeutic Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2014-2019E Table Europe RNAi For Therapeutic Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2014-2019E Table Europe RNAi For Therapeutic Import and Export from 2014-2019E Table Europe RNAi For Therapeutic Value ($) by Type (2014-2019E) Table Europe RNAi For Therapeutic Production by Type (2014-2019E) Table Europe RNAi For Therapeutic Consumption by Application (2014-2019E) Table Europe RNAi For Therapeutic Consumption by Country (2014-2019E) Table Europe RNAi For Therapeutic Consumption Value ($) by Country (2014-2019E) Figure Europe RNAi For Therapeutic Market PEST Analysis Table Asia-Pacific RNAi For Therapeutic Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2014-2019E Table Asia-Pacific RNAi For Therapeutic Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2014-2019E Table Asia-Pacific RNAi For Therapeutic Import and Export from 2014-2019E Table Asia-Pacific RNAi For Therapeutic Value ($) by Type (2014-2019E) Table Asia-Pacific RNAi For Therapeutic Production by Type (2014-2019E) Table Asia-Pacific RNAi For Therapeutic Consumption by Application (2014-2019E) Table Asia-Pacific RNAi For Therapeutic Consumption by Country (2014-2019E) Table Asia-Pacific RNAi For Therapeutic Consumption Value ($) by Country (2014-2019E) Figure Asia-Pacific RNAi For Therapeutic Market PEST Analysis Table Latin America RNAi For Therapeutic Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2014-2019E Table Latin America RNAi For Therapeutic Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2014-2019E Table Latin America RNAi For Therapeutic Import and Export from 2014-2019E Table Latin America RNAi For Therapeutic Value ($) by Type (2014-2019E) Table Latin America RNAi For Therapeutic Production by Type (2014-2019E) Table Latin America RNAi For Therapeutic Consumption by Application (2014-2019E) Table Latin America RNAi For Therapeutic Consumption by Country (2014-2019E) Table Latin America RNAi For Therapeutic Consumption Value ($) by Country (2014-2019E) Figure Latin America RNAi For Therapeutic Market PEST Analysis Table Middle East & Africa RNAi For Therapeutic Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2014-2019E Table Middle East & Africa RNAi For Therapeutic Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2014-2019E Table Middle East & Africa RNAi For Therapeutic Import and Export from 2014-2019E Table Middle East & Africa RNAi For Therapeutic Value ($) by Type (2014-2019E) Table Middle East & Africa RNAi For Therapeutic Production by Type (2014-2019E) Table Middle East & Africa RNAi For Therapeutic Consumption by Application (2014-2019E) Table Middle East & Africa RNAi For Therapeutic Consumption by Country (2014-2019E) Table Middle East & Africa RNAi For Therapeutic Consumption Value ($) by Country (2014-2019E) Figure Middle East & Africa RNAi For Therapeutic Market PEST Analysis Table Global RNAi For Therapeutic Value ($) and Growth Rate Forecast by Region (2018-2026) Table Global RNAi For Therapeutic Production and Growth Rate Forecast by Region (2019-2026) Table Global RNAi For Therapeutic Consumption and Growth Rate Forecast by Region (2019-2026) Table Global RNAi For Therapeutic Production and Growth Rate Forecast by Type (2019-2026) Table Global RNAi For Therapeutic Consumption and Growth Rate Forecast by Application (2019-2026)